The mechanistic foundations and emerging therapeutic strategies of MNP‐based cancer treatment are synthesised, current limitations are evaluated, and future directions are outlined, including the integration of intelligent design frameworks, personalised nanomedicine, and clinically translatable manufacturing approache...
Shivani Kadam, Rahul M. Sonavale, Ratnesh Das et al.· Nano Select· 0 citations
Overall, polymer-metal hybrid nanoparticles represent a versatile and promising nanomedicine platform for precision breast cancer management, with continued advances in nanoparticle engineering, safety assessment, and clinical validation expected to facilitate their successful translation into personalized oncology.
Pranoti A. Mane, A. Mohite, K. Datkhile et al.· Cureus· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.